The S&A FDA Report, written by Dr. George Huang, is a sophisticated trading service that pinpoints the precise dates of huge stock moves using what are known as FDA "approvable letters." Through an extensive eight-year back study, Dr. Huang found that approvable letters are one of the most accurate indicators of stock price movement – in-the-know traders can make an average of 75% a year.

Dr. Huang is perhaps one of the smartest and most qualified analysts we've ever hired. He graduated high school two years early. By age 19, he was working to secure private seed capital for a Vancouver-based firm called Helios Bioinformatics. Dr. Huang then spent five years at Johns Hopkins, working on his PhD in cellular & molecular medicine under the tutelage of a Nobel laureate in chemistry. 

Now, Dr. Huang tracks these FDA approvable-letter situations... and alerts his readers to upcoming trades using his proprietary four-pronged strategy, which focuses his attention on the smallest companies in the market with the potential for the biggest moves.